N. Paleari

Safety of Bariatric Surgery in ≥ 65-Year-Old Patients During the COVID-19 Pandemic

I. Kempeneers, G. Silecchia, C. Boru, 2022, Obesity Surgery.

Effect of BMI on safety of bariatric surgery during the COVID-19 pandemic, procedure choice, and safety protocols – An analysis from the GENEVA Study

I. Kempeneers, G. Silecchia, C. Boru, 2022, Obesity Research & Clinical Practice.

The development of minimal access hepatopancreatobiliary surgery

H. Asbun, J. Stauffer, R. Puri, 2016 .

30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries

I. Kempeneers, M. Motwani, G. Silecchia, 2021, Obesity Surgery.

30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data

I. Kempeneers, G. Silecchia, C. Boru, 2021, International Journal of Obesity.

Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study

B. Zilberstein, C. Ludwig, H. Heneghan, 2020, The Lancet Diabetes & Endocrinology.

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients

J. Bayo, G. Mazzolini, G. Menaldi, 2023, International journal of molecular sciences.